Dried blood plasma

Auto-translated from lt

Original title: Sausa kraujo plazma

GYNYBOS RESURSŲ AGENTŪRA PRIE KAM

Published: Jun 30, 2026

Updated: Jun 30, 2026

Source: TED - Tenders Electronic Daily (EU)

About This Opportunity

This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals. Located in Lithuania, Europe, this opportunity is open to firms and consortiums. Proposals must be submitted before August 4, 2026.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. Interested parties should review the full documentation on the original source before submitting their proposal.

Description

Original language: lt

This tender, originating from Lithuania, concerns the procurement of dried blood plasma ('Sausa kraujo plazma'). The contracting authority intends to acquire this specific biological product, likely for medical, research, or pharmaceutical purposes. As a procurement involving biological materials, stringent quality control and regulatory compliance are paramount. Potential bidders are expected to be manufacturers or authorized distributors of dried blood plasma. Key requirements will include adherence to international standards (such as GMP - Good Manufacturing Practice), specific purity levels, safety certifications, and traceability of the product. The tender documentation will detail the required quantities, specifications (e.g., source material, processing methods, shelf life), packaging requirements, and delivery conditions. Bidders must provide comprehensive documentation proving their compliance with relevant health and safety regulations, quality management systems, and their capacity to supply the specified product reliably. Evaluation criteria will heavily weigh product quality, safety compliance, supplier credentials, and the ability to meet delivery schedules. This tender is crucial for entities requiring high-quality biological components for healthcare applications.

Data provenance

This notice is sourced from TED - Tenders Electronic Daily (EU) and was originally published on June 30, 2026. Last refreshed today. Original language: lt. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About GYNYBOS RESURSŲ AGENTŪRA PRIE KAM

GYNYBOS RESURSŲ AGENTŪRA PRIE KAM has issued 80 procurement notices on BidsFactory, including 17 currently open and 29 awarded contracts. Activity concentrates in General Supplies & Services, Health & Medical, and Security, Defense & Justice. All notices are published for Lithuania. Notices are distributed via TED - Tenders Electronic Daily (EU). Most recent publication: June 30, 2026.

Frequently asked questions about this tender

Where will the contract be performed?

The contract is for delivery in Lithuania. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.

How can I submit a bid?

Visit TED - Tenders Electronic Daily (EU) to access the full notice, required documents, and submission instructions provided by the contracting authority.

When does this tender close?

The submission deadline is August 4, 2026. You have 35 days left to prepare and submit your proposal to the contracting authority.

Who is the contracting authority?

This notice was issued by GYNYBOS RESURSŲ AGENTŪRA PRIE KAM in Lithuania. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

What type of contract is this?

This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.